Skip To Main Content
Graham Lewis on Muck Rack

Graham Lewis

As seen in: Medium, Genius, Constant Contact, ITV News West Country, Royal Society of Chemistry, Littlehampton Gazette, SussexWorld, Worthing Herald, Lexology, Mondaq and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Graham

Contact Graham, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

SPC Manufacturing Waiver

|
By Graham Lewis, Chris Milton, Ravi Srinivasan
| Mondaq
With the entry into force of Regulation (EU) 2019/933 on 1 July 2019, the EU introduced a so-called “manufacturing waiver” by amending existing Regulation (EC) 469/2009 concerning supplementary protection certificates (SPCs).
Open in Who Shared Issue with article?

SPCs To Keep The CJEU Busy: Four Referrals To Watch

|
By Graham Lewis, Chris Milton
| Mondaq
The last two years have seen a steady flow of referrals to the CJEU for SPC matters. With three referrals already pending (all dealing with various questions around the definition of a medicinal product and the “first” marketing authorisation) there is now news of a fourth case concerned with the SPC manufacturing waiver. In this article we briefly summarise all four SPC cases awaiting the Court’s attention, starting with the most recent referral.
Open in Who Shared Issue with article?

Trans-Atlantic Alignment? US Federal Circuit Moves Closer To The EPO/UPC Approach For Broad Antibody Claims To Medical Uses

|
By Graham Lewis
| Mondaq
Graham Lewis’s articles from J A Kemp LLP are most popular: with readers working within the Technology industries We recently commented on a welcome alignment of the EPO and UPC concerning (in part) the extent to which an antibody may be defined broadly in a medical use claim.
Open in Who Shared Issue with article?
See all 93 licensed articles (105 Total)